Clinical trial
Optimizing Naltrexone for Individuals of East Asian Descent
NCT02026011 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Optimizing Naltrexone for Individuals of East Asian Descent
- Lead sponsor
- University of California, Los Angeles
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- September 30, 2016
- Enrollment
- 87 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol use disorder